Healthcare ETFs: I Prefer VHT's Growth To XLV's Stability

Core Insights - The US healthcare industry is experiencing new growth opportunities due to innovations such as GLP-1 agonists and gene therapies, following several years of low returns and volatility [1] Group 1: Industry Overview - The healthcare sector has faced challenges in the past three years, characterized by significant volatility and low returns [1] - Recent innovations are providing tailwinds that could enhance the sector's performance moving forward [1]